About this trial

This registry is designed to collect comprehensive information about the molecular genetic diagnoses of individuals with otoferlin-associated hearing impairment and clinical information to support a natural history study.

Eligibility criteria

Qualifiers

A molecular genetic diagnosis involving biallelic variants in otoferlin (OTOF) and audiometry

Disqualifiers

Patients with evidence of non-OTOF molecular genetic diagnoses

Trial design

Treatments tested in this trial

  • Molecular genetic testing and audiometry

Treatment groups

100 Participants
are divided into 1 treatment group

Locations

1
University Medical Center Goettingen37075, GoettigenLower Saxony, Germany

Sponsors and collaborators

Tobias Moser

Lead sponsor

University Medical Center Goettingen

Sponsor institution